Dr. Reddy’s Laboratories rises on getting USFDA’s approval for rituximab biosimilar
Mumbai, August 3 (Udaipur Kiran): Dr. Reddy’s Laboratories is currently trading at Rs. 1163.35, up by 15.75 points or 1.37% from its previous closing of Rs. 1147.60 on the BSE. The scrip opened at Rs. 1174.95 and has touched a high and low of Rs. 1175.00 and Rs. 1161.05 respectively. So far 18082 shares were … Read more